A Vaccine Model for COVID-19

Simulate the introduction of a vaccine in the COVID-19 pandemic, focused on the US.

Launch Tool

You must login before you can run this tool.

Version 1.0 - published on 25 Jan 2021

doi:10.21981/8274-M636 cite this

Open source: license | download

View All Supporting Documents

Category

Tools

Published on

Abstract

Since the beginning of the COVID-19 pandemic, there has been much talk of developing a vaccine to build immunity and end the rise in cases. But what happens when a vaccine is finally introduced? Through mathematical modeling, we can predict how a vaccine would impact the trajectory of the pandemic. This app works through 3 compartmental epidemiological models for the introduction of a vaccine in the COVID-19 pandemic in the US. You'll examine the behavior of each model and adjust variables to determine what would happen if a vaccine were introduced. After the models are built, you will use real US COVID-19 data to find variables that can be used to simulate a US-specific scenario for vaccination. These fitted models are then used to explore the vaccination conditions necessary to end the pandemic.

Powered by

Jupyter Notebook

Credits

Project Creator and Developer: Kali Konstantinopoulos

Project Advisors: Dr. James Glazier, Josua Aponte-Serrano

References

AJMC Staff. (2020, November 25). A Timeline of COVID-19 Developments in 2020. AJMC.

    https://www.ajmc.com/view/a-timeline-of-covid19-developments-in-2020

Clinical Care Guidance. (2020, December 8). CDC. 

    https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html

Dong, E., Hongru D., and Gardner, L. (2020). An Interactive Web-Based Dashboard to Track

COVID-19 in Real Time.In The Lancet Infectious Diseases. Lancet Publishing Group.

    https://doi.org/10.1016/S1473-3099(20)30120-1

FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use

Authorization for Second COVID-19 Vaccine. (2020, December 18). FDA. 

    https://www.fda.gov/news-events/press-announcements/fda-takes-additional-action-fight-against-covid-19-issuing-emergency-use-authorization-second-covid

Frequently Asked Questions. (2020, December 17). CDC.

    https://www.cdc.gov/coronavirus/2019-ncov/faq.html

Georgiou, A. (2020, November 17). It’s Been Exactly One Year Since the First Cse of COVID

    Was Found in China.Newsweek. https://www.newsweek.com/one-year-first-covid-case-china-1547200

Gumel, A. B., McCluskey, C. C., & Watmough, J. (2006). An SVEIR model for assessing potential impact

    of an imperfect anti-SARS vaccine. Mathematical Biosciences & Engineering3(3), 485-512.

    https://doi.org/10.3934/mbe.2006.3.485

How does the newly authorized Moderna COVID-19 vaccine compare to Pfizer’s?(2020, December 18).

    ScienceNews. https://www.sciencenews.org/article/covid-19-coronavirus-moderna-vaccine-fda-approval

Mahase, E. (2020). Covid-19: Pfizer vaccine efficacy was 52% after first dose and 95% after second dose,

    paper shows. BMJ. https://doi.org/10.1136/bmj.m4826

Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations.(2020, March 29). World Health Organization. https://www.who.int/news-

    room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc

    precaution-recommendations

Pfizer-BioNTech COVID-19 Vaccine. (2020, December 18). FDA.

    https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine

Cite this work

Researchers should cite this work as follows:

  • Kali Nicole Konstantinopoulos, James A Glazier, Josua Oscar Aponte-Serrano (2021), "A Vaccine Model for COVID-19," https://nanohub.org/resources/covidvaccinemod. (DOI: 10.21981/8274-M636).

    BibTex | EndNote

Tags